May 5, 2017 / 11:26 AM / 4 months ago

BRIEF-Ardelyx Qtrly loss per share $0.59

May 5 (Reuters) - Ardelyx Inc:

* Ardelyx reports first quarter 2017 operating results and highlights recent progress

* Ardelyx Inc - on track to report data from t3mpo-1 phase 3 trial of tenapanor in ibs-c in q2 2017

* Ardelyx Inc qtrly loss per share $0.59

* Q1 earnings per share view $-0.68 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below